Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $20.4000 (4.62%) ($19.8000 - $22.0000) on Wed. Feb. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.19% (three month average) | RSI | 64 | Latest Price | $20.4000(4.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TBT(9%) EWG(8%) PEJ(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.595% in a week (0% probabilities). TLT(-9%) GLD(-9%) SLV(-8%) GDX(-8%) SIL(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.595% (StdDev 5.19%) | Hourly BBV | 0 () | Intraday Trend | 2% | | | |
|
5 Day Moving Average | $18.54(10.03%) | 10 Day Moving Average | $18.58(9.8%) | 20 Day Moving Average | $18.2(12.09%) | To recent high | -24.4% | To recent low | 39.7% | Market Cap | $402m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |